Antithyroid Drug Treatment in Graves’ Disease
Graves’ disease is associated with thyrotropin (TSH) receptor stimulating antibody, for which there is no therapeutic agent. This disease is currently treated through inhibition of thyroid hormone synthesis or destruction of the thyroid gland. Recurrence after antithyroid drug (ATD) treatment is com...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Korean Endocrine Society
2021-06-01
|
| סדרה: | Endocrinology and Metabolism |
| נושאים: | |
| גישה מקוונת: | http://www.e-enm.org/upload/pdf/enm-2021-1070.pdf |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
